Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. May 15, 2026; 18(5): 116163
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.116163
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.116163
Table 1 E74-like ETS transcription factor 3 and clinicopathological characteristics of gastric cancer patients (n = 100)
| Variable | ELF3 expression | P value | ||
| Low (52) | High (48) | |||
| Age (years) | < 60 | 18 | 15 | 0.724 |
| ≥ 60 | 34 | 33 | ||
| Gender | Male | 35 | 29 | 0.478 |
| Female | 17 | 19 | ||
| Tumor size (cm) | < 5 | 31 | 17 | 0.015 |
| ≥ 5 | 21 | 31 | ||
| T stage | T1 + T2 | 18 | 4 | 0.090 |
| T3 + T4 | 34 | 42 | ||
| N stage | N0 + N1 | 28 | 15 | 0.023 |
| N2 + N3 | 24 | 33 | ||
| TNM stage | I + II | 30 | 15 | 0.008 |
| III + IV | 22 | 33 | ||
| Ki-67 | Low | 30 | 20 | 0.001 |
| High | 22 | 28 | ||
| E-cadherin | Low | 20 | 29 | 0.028 |
| High | 32 | 19 | ||
Table 2 Univariate and multivariate analyses of prognostic factors for overall survival of stomach adenocarcinoma patients in the study cohort
| Variables | Univariate analysis | Multivariate analysis | ||||
| HR | 95%CI | P value | HR | 95%CI | P value | |
| Age (years) | ||||||
| < 60 | Reference | |||||
| ≥ 60 | 0.901 | 0.526-1.544 | 0.704 | |||
| Gender | ||||||
| Female | Reference | |||||
| Male | 1.166 | 0.672-2.023 | 0.585 | |||
| Tumor size (cm) | ||||||
| < 5 | Reference | Reference | ||||
| ≥ 5 | 2.342 | 1.355-4.047 | 0.002 | 1.351 | 0.729-2.503 | 0.339 |
| T stage | ||||||
| T1 + T2 | Reference | Reference | ||||
| T3 + T4 | 3.427 | 1.366-8.594 | 0.009 | 1.117 | 0.402-3.100 | 0.832 |
| N stage | ||||||
| N0 + N1 | Reference | Reference | ||||
| N2 + N3 | 2.421 | 1.380-4.248 | 0.002 | 0.497 | 0.106-2.337 | 0.376 |
| TNM stage | ||||||
| I + II | Reference | Reference | ||||
| III + IV | 2.812 | 1.588-4.979 | < 0.001 | 3.652 | 0.750-17.789 | 0.109 |
| ELF3 expression | ||||||
| Low | Reference | Reference | ||||
| High | 5.148 | 2.793-9.488 | < 0.001 | 4.154 | 2.135-8.081 | < 0.001 |
| Vascular invasion | ||||||
| No | Reference | Reference | ||||
| Yes | 2.672 | 1.405-5.081 | 0.003 | 2.313 | 1.196-4.474 | 0.013 |
| Ki-67 | ||||||
| Low | Reference | |||||
| High | 0.759 | 0.450-1.282 | 0.303 | |||
| E-cadherin | ||||||
| Low | Reference | |||||
| High | 0.649 | 0.384-1.096 | 0.106 | |||
Table 3 Correlation between E74-like ETS transcription factor 3 and related gene markers of immune cells in TIMER
| Description | Gene markers | None correlation coefficient | P value | Purity correlation coefficient | P value |
| CD8+ T cell | CD8A | -0.150 | 0.0023 | -0.124 | 0.0156 |
| CD8B | -0.135 | 0.0057 | -0.126 | 0.0142 | |
| T cell | CD3D | -0.203 | -0.168 | 0.0011 | |
| CD3E | -0.150 | 0.0021 | -0.112 | 0.0293 | |
| CD2 | -0.177 | -0.139 | 0.0068 | ||
| B cell | CD19 | -0.220 | -0.184 | ||
| CD79A | -0.220 | -0.174 | |||
| Monocyte | CD86 | -0.180 | -0.158 | 0.0021 | |
| TAM | CCL2 | -0.343 | -0.331 | ||
| CD68 | 0.168 | 0.201 | |||
| IL10 | -0.189 | -0.161 | 0.0017 | ||
| M1 macrophage | IRF5 | -0.018 | 0.7209 | -0.012 | 0.8206 |
| M2 macrophage | CD163 | -0.120 | 0.0148 | -0.099 | 0.0538 |
| VSIG4 | -0.176 | -0.167 | 0.0011 | ||
| MS4A4A | -0.211 | -0.197 | |||
| Neutrophils | CCR7 | -0.242 | -0.199 | ||
| NK cell | KIR2DL1 | -0.120 | 0.0147 | -0.108 | 0.0359 |
| KIR2DL3 | -0.100 | 0.0417 | -0.069 | 0.1820 | |
| KIR2DL4 | 0.003 | 0.9467 | 0.028 | 0.5866 | |
| KIR3DL1 | -0.120 | 0.0143 | -0.092 | 0.0725 | |
| KIR3DL2 | -0.091 | 0.0632 | -0.066 | 0.1979 | |
| KIR3DL3 | 0.156 | 0.0015 | 0.152 | 0.0029 | |
| KIR2DS4 | -0.057 | 0.2480 | -0.038 | 0.4560 | |
| DC | HLA-DPB1 | -0.137 | 0.0053 | -0.094 | 0.0676 |
| HLA-DQB1 | -0.068 | 0.1669 | -0.011 | 0.8379 | |
| HLA-DRA | -0.071 | 0.1492 | -0.030 | 0.5560 | |
| HLA-DPA1 | -0.085 | 0.0831 | -0.041 | 0.4245 | |
| Th1 cell | STAT4 | -0.232 | -0.191 | ||
| STAT1 | 0.087 | 0.0766 | 0.120 | 0.0191 | |
| Th2 cell | GATA3 | -0.309 | -0.297 | ||
| STAT6 | 0.210 | 0.205 | |||
| STAT5A | -0.018 | 0.7152 | -0.007 | 0.8874 | |
| IL13 | -0.068 | 0.1688 | -0.045 | 0.3857 | |
| Th17 cell | STAT3 | 0.063 | 0.2023 | 0.076 | 0.1417 |
| IL17A | 0.138 | 0.0048 | 0.155 | 0.0024 | |
| Treg | FOXP3 | -0.031 | 0.5313 | 0.022 | 0.6710 |
| CCR8 | -0.062 | 0.2108 | -0.033 | 0.5251 | |
| STAT5B | -0.114 | 0.0204 | -0.100 | 0.0508 | |
| T-cell exhaustion | CTLA4 | -0.143 | 0.0035 | -0.112 | 0.0297 |
| LAG3 | -0.109 | 0.0258 | -0.081 | 0.1163 | |
| GZMB | -0.044 | 0.3673 | -0.003 | 0.9570 |
Table 4 Correlation between E74-like ETS transcription factor 3 and related gene markers of immune cells in GEPIA
| Description | Gene markers | Tumor correlation coefficient | P value | Normal | P value |
| CD8+ T cell | CD8A | -0.170 | 0.230 | 0.1700 | |
| CD8B | -0.140 | 0.0055 | 0.180 | 0.2900 | |
| T Cell | CD3D | -0.220 | 0.230 | 0.1800 | |
| CD3E | -0.160 | 0.290 | 0.0820 | ||
| CD2 | -0.180 | 0.290 | 0.0870 | ||
| B Cell | CD19 | -0.210 | 0.210 | 0.2200 | |
| CD79A | -0.250 | 0.380 | 0.0230 | ||
| Monocyte | CD86 | -0.180 | 0.220 | 0.1900 | |
| TAM | CCL2 | -0.310 | -0.530 | 0.0010 | |
| CD68 | 0.170 | 0.650 | |||
| IL10 | -0.170 | 0.045 | 0.7900 | ||
| M1 macrophage | IRF5 | 0.048 | 0.3300 | 0.650 | |
| M2 macrophage | CD163 | -0.200 | -0.470 | 0.0041 | |
| VSIG4 | -0.160 | 0.0016 | -0.270 | 0.1200 | |
| MS4A4A | -0.180 | -0.480 | 0.0028 | ||
| Neutrophils | CCR7 | -0.240 | 0.450 | 0.0058 | |
| NK cell | KIR2DL1 | -0.067 | 0.1800 | -0.094 | 0.5800 |
| KIR2DL3 | -0.048 | 0.3400 | 0.098 | 0.5700 | |
| KIR2DL4 | 0.170 | 0.7300 | 0.550 | ||
| KIR3DL1 | -0.110 | 0.0250 | -0.002 | 0.9900 | |
| KIR3DL2 | -0.052 | 0.3000 | 0.210 | 0.2100 | |
| KIR3DL3 | 0.160 | 0.0011 | 0.140 | 0.4300 | |
| KIR2DS4 | -0.001 | 0.9900 | 0.120 | 0.4900 | |
| DC | HLA-DPB1 | -0.110 | 0.0230 | 0.170 | 0.3300 |
| HLA-DQB1 | -0.077 | 0.1200 | 0.110 | 0.5200 | |
| HLA-DRA | -0.075 | 0.1300 | 0.240 | 0.1700 | |
| HLA-DPA1 | -0.075 | 0.1300 | 0.150 | 0.3900 | |
| Th1 cell | STAT4 | -0.220 | 0.097 | 0.5800 | |
| STAT1 | 0.120 | 0.0160 | 0.110 | 0.5100 | |
| Th2 cell | GATA3 | -0.290 | 0.420 | 0.0120 | |
| STAT6 | 0.320 | 0.110 | 0.5400 | ||
| STAT5A | 0.047 | 0.3400 | -0.300 | 0.0770 | |
| IL13 | -0.070 | 0.1600 | -0.450 | 0.0065 | |
| Th17 cell | STAT3 | 0.130 | 0.0068 | -0.034 | 0.8400 |
| IL17A | 0.130 | 0.0100 | 0.370 | 0.0290 | |
| Treg | FOXP3 | -0.052 | 0.2900 | 0.450 | 0.0060 |
| CCR8 | -0.047 | 0.3500 | 0.550 | ||
| STAT5B | -0.046 | 0.3600 | -0.390 | 0.0180 | |
| T-cell exhaustion | CTLA4 | -0.130 | 0.0100 | 0.340 | 0.0420 |
| LAG3 | -0.130 | 0.0085 | -0.058 | 0.7300 | |
| GZMB | -0.056 | 0.2600 | 0.290 | 0.0900 |
- Citation: Sun ZS, Li CL, Jing HH, Wang ZZ, Zheng LB. ELF3 emerges as a novel prognostic indicator implicated in gastric cancer progression and correlated with unfavorable clinical outcomes. World J Gastrointest Oncol 2026; 18(5): 116163
- URL: https://www.wjgnet.com/1948-5204/full/v18/i5/116163.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i5.116163